PTCT Earnings Ptc Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–37 of 37
| Q2 2026 | 2026-06-30 | 0.90 | 2026-07-30 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.03 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | 7.78 | 2026-02-19 | 10-K |
| Q3 2025 | 2025-09-30 | 9.45 | 2025-11-04 | 10-Q |
| Q2 2026 | 2025-06-30 | 9.29 | 2026-07-30 | 10-Q |
| Q1 2026 | 2025-03-31 | 10.04 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -4.73 | 2026-02-19 | 10-K |
| Q3 2025 | 2024-09-30 | -3.88 | 2025-11-04 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.49 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.20 | 2025-05-06 | 10-Q |
| FY 2025 | 2023-12-31 | -8.37 | 2026-02-19 | 10-K |
| Q3 2024 | 2023-09-30 | -6.31 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -4.55 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.88 | 2024-04-25 | 10-Q |
| FY 2024 | 2022-12-31 | -7.79 | 2025-02-27 | 10-K |
| Q3 2023 | 2022-09-30 | -5.43 | 2023-10-26 | 10-Q |
| Q2 2023 | 2022-06-30 | -3.91 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.78 | 2023-04-27 | 10-Q |
| FY 2023 | 2021-12-31 | -7.43 | 2024-02-29 | 10-K |
| Q3 2022 | 2021-09-30 | -5.41 | 2022-10-27 | 10-Q |
| Q2 2022 | 2021-06-30 | -3.51 | 2022-08-04 | 10-Q |
| Q1 2022 | 2021-03-31 | -1.83 | 2022-05-03 | 10-Q |
| FY 2022 | 2020-12-31 | -6.64 | 2023-02-21 | 10-K |
| FY 2021 | 2019-12-31 | -4.27 | 2022-02-22 | 10-K |
| FY 2014 | 2014-12-31 | -2.97 | 2015-03-02 | 10-K |
| FY 2014 | 2014-09-30 | -0.93 | 2015-03-02 | 10-K |
| FY 2014 | 2014-06-30 | -0.86 | 2015-03-02 | 10-K |
| FY 2014 | 2014-03-31 | -0.58 | 2015-03-02 | 10-K |
| FY 2014 | 2013-12-31 | -5.18 | 2015-03-02 | 10-K |
| FY 2014 | 2013-09-30 | -0.19 | 2015-03-02 | 10-K |
| FY 2014 | 2013-06-30 | -5.51 | 2015-03-02 | 10-K |
| FY 2014 | 2013-03-31 | -6527.30 | 2015-03-02 | 10-K |
| FY 2014 | 2012-12-31 | 42.50 | 2015-03-02 | 10-K |
| FY 2013 | 2012-09-30 | -1605.53 | 2014-03-06 | 10-K |
| FY 2013 | 2012-06-30 | 48.29 | 2014-03-06 | 10-K |
| FY 2013 | 2012-03-31 | -5992.61 | 2014-03-06 | 10-K |
| FY 2013 | 2011-12-31 | 4.55 | 2014-03-06 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.